The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Open accessAbstract
Seven-transmembrane receptors (7TMRs; also known as G protein-coupled receptors) are the largest class of receptors in the human genome and are common targets for therapeutics. Originally identified as mediators of 7TMR desensitization, β-arrestins (arrestin 2 and arrestin 3) are now recognized as true adaptor proteins that transduce signals to multiple effector pathways. Signalling that is mediated by β-arrestins has distinct biochemical and functional consequences from those mediated by G proteins, and several biased ligands and receptors have been identified that preferentially signal through either G protein- or β-arrestin-mediated pathways. These ligands are not only useful tools for investigating the biochemistry of 7TMR signalling, they also have the potential to be developed into new classes of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Self-citationDe Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
Self-citationStructural diversity of G protein-coupled receptors and significance for drug discovery
Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,492
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Self-citationβ-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
Self-citationβ-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
Self-citationβ-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
Self-citationEnhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Self-citationAn Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Self-citationRole of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 860
Self-citationActivation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 831
Self-citationDeFea, K. A., Zalevsky, J., Thoma, M. S., Déry, O., Mullins, R. D., & Bunnett, N. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1267 · Cited by 822
Wilden, U., Hall, S. W., & Kühn, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1174 · Cited by 791
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759
Self-citationWei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Self-citationThe genetic design of signaling cascades to record receptor activation
Barnea, G., Strapps, W., Herrada, G., Berman, Y., Ong, J., Kloss, B., Axel, R., & Lee, K. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710487105 · Cited by 678
Agonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications
Hanyaloglu, A. C., & Zastrow, M. V. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094830 · Cited by 609
β-Arrestin-biased ligands at seven-transmembrane receptors
Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606
Self-citationA unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Self-citationAkt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508
Self-citationTargeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
Perry, S. J., Baillie, G. S., Kohout, T. A., McPhee, I., Magiera, M. M., Ang, K. L., Miller, W. E., McLean, A. J., Conti, M., Houslay, M. D., et al. (2002) · Science · doi:10.1126/science.1074683 · Cited by 506
Self-citationBenovic, J. L., Kühn, H., Weyand, I., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8879 · Cited by 482
Self-citationGesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513380200 · Cited by 476
Self-citationβ-Adrenergic Receptor Kinase: Primary Structure Delineates a Multigene Family
Benovic, J. L., DeBlasi, A., Stone, W. C., Caron, M. G., & Lefkowitz, R. J. (1989) · Science · doi:10.1126/science.2552582 · Cited by 444
Self-citationLight-dependent phosphorylation of rhodopsin: number of phosphorylation sites
Wilden, U., & Kuehn, H. (1982) · Biochemistry · doi:10.1021/bi00541a032 · Cited by 440
Measurement of the millisecond activation switch of G protein–coupled receptors in living cells
Vilardaga, J.-P., Bünemann, M., Krasel, C., Castro, M., & Lohse, M. J. (2003) · Nature Biotechnology · doi:10.1038/nbt838 · Cited by 431
Functional specialization of β-arrestin interactions revealed by proteomic analysis
Xiao, K., McClatchy, D. B., Shukla, A. K., Zhao, Y., Chen, M., Shenoy, S. K., Yates, J. R., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704849104 · Cited by 420
Self-citationβ-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 418
Self-citationHistorical review: A brief history and personal retrospective of seven-transmembrane receptors
Lefkowitz, R. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.006 · Cited by 417
Self-citationDeFea, K. A., Vaughn, Z. D., O'Bryan, E. M., Nishijima, D., Déry, O., & Bunnett, N. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190276697 · Cited by 405
Tohgo, A., Pierce, K. L., Choy, E. W., Lefkowitz, R. J., & Luttrell, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106457200 · Cited by 396
Self-citationLight dependent phosphorylation of rhodopsin by ATP
Kühn, H., & Dreyer, W. J. (1972) · FEBS Letters · doi:10.1016/0014-5793(72)80002-4 · Cited by 367
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.004 · Cited by 363
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J.-M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362
Self-citationTohgo, A., Choy, E. W., Gesty-Palmer, D., Pierce, K. L., Laporte, S., Oakley, R. H., Caron, M. G., Lefkowitz, R. J., & Luttrell, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212231200 · Cited by 359
Self-citationKohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S., & Struthers, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402125200 · Cited by 333
Eason, M. G., Kurose, H., Holt, B. D., Raymond, J. R., & Liggett, S. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49605-1 · Cited by 330
Balabanian, K. (2005) · Blood · doi:10.1182/blood-2004-06-2289 · Cited by 322
Kang, J., Shi, Y., Xiang, B., Qu, B., Su, W., Zhu, M., Zhang, M., Bao, G., Wang, F., Zhang, X., et al. (2005) · Cell · doi:10.1016/j.cell.2005.09.011 · Cited by 318
Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways
Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., & Pei, G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00216-3 · Cited by 312
Whalen, E. J., Foster, M. W., Matsumoto, A., Ozawa, K., Violin, J. D., Que, L. G., Nelson, C. D., Benhar, M., Keys, J. R., Rockman, H. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.02.046 · Cited by 311
Self-citationLight-dependent phosphorylation of rhodopsin. Purification and properties of rhodopsin kinase.
Shichi, H., & Somers, R. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38026-2 · Cited by 291
Galandrin, S., & Bouvier, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026716 · Cited by 291
β-arrestins: traffic cops of cell signaling
Lefkowitz, R. J., & Whalen, E. J. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.01.001 · Cited by 282
Self-citationZidar, D. A., Violin, J. D., Whalen, E. J., & Lefkowitz, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904361106 · Cited by 278
Self-citationβ-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276
β-Arrestin–Mediated Localization of Smoothened to the Primary Cilium
Kovacs, J. J., Whalen, E. J., Liu, R., Xiao, K., Kim, J., Chen, M., Wang, J., Chen, W., & Lefkowitz, R. J. (2008) · Science · doi:10.1126/science.1157983 · Cited by 274
Self-citationβ-arrestin signaling and regulation of transcription
Ma, L., & Pei, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03338 · Cited by 268
Role of β-arrestin 1 in the metastatic progression of colorectal cancer
Buchanan, F. G., Gorden, D. L., Matta, P., Shi, Q., Matrisian, L. M., & DuBois, R. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510562103 · Cited by 267
Enjalbert, A., & Bockaert, J. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14305-8 · Cited by 262
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
Drake, M. T., Violin, J. D., Whalen, E. J., Wisler, J. W., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708118200 · Cited by 254
Self-citationβ-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
Witherow, D. S., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402851101 · Cited by 254
Self-citationβ-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
Walters, R. W., Shukla, A. K., Kovacs, J. J., Violin, J. D., DeWire, S. M., Lam, C. M., Chen, J. R., Muehlbauer, M. J., Whalen, E. J., & Lefkowitz, R. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36806 · Cited by 240
Self-citationHolloway, A. C., Qian, H., Pipolo, L., Ziogas, J., Miura, S.-I., Karnik, S., Southwell, B. R., Lew, M. J., & Thomas, W. G. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12327-9 · Cited by 238
Regulation of tyrosine kinase activation and granule release through β-arrestin by CXCR1
Barlic, J., Andrews, J. D., Kelvin, A. A., Bosinger, S. E., DeVries, M. E., Xu, L., Dobransky, T., Feldman, R. D., Ferguson, S. S. G., & Kelvin, D. J. (2000) · Nature Immunology · doi:10.1038/79767 · Cited by 232
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
Shukla, A. K., Violin, J. D., Whalen, E. J., Gesty-Palmer, D., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804246105 · Cited by 231
Self-citationA Molecular Pathway for Light-Dependent Photoreceptor Apoptosis in Drosophila
Kiselev, A., Socolich, M., Vinós, J., Hardy, R. W., Zuker, C. S., & Ranganathan, R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00092-1 · Cited by 230
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Schmid, C. L., Raehal, K. M., & Bohn, L. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708862105 · Cited by 229
Alloway, P. G., Howard, L., & Dolph, P. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)00091-x · Cited by 224
Groer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224
Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J., & Pei, G. (2009) · Nature · doi:10.1038/nature07617 · Cited by 217
Rajagopal, K., Whalen, E. J., Violin, J. D., Stiber, J. A., Rosenberg, P. B., Premont, R. T., Coffman, T. M., Rockman, H. A., & Lefkowitz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607583103 · Cited by 214
Self-citationKenakin, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.009 · Cited by 213
The Cubic Ternary Complex Receptor-Occupancy Model III. Resurrecting Efficacy
Weiss, J. M., Morgan, P. H., Lutz, M. W., & Kenakin, T. P. (1996) · Journal of Theoretical Biology · doi:10.1006/jtbi.1996.0139 · Cited by 212
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
Bohn, L. M., Gainetdinov, R. R., Sotnikova, T. D., Medvedev, I. O., Lefkowitz, R. J., Dykstra, L. A., & Caron, M. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10265.2003 · Cited by 210
Self-citationGPCR functional selectivity has therapeutic impact
Mailman, R. B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.002 · Cited by 208
Ge, L., Ly, Y., Hollenberg, M., & DeFea, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300573200 · Cited by 205
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., & Luttrell, L. M. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000071 · Cited by 205
Self-citationBarnes, W. G., Reiter, E., Violin, J. D., Ren, X.-R., Milligan, G., & Lefkowitz, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412924200 · Cited by 194
Self-citationAgonist-Receptor-Arrestin, an Alternative Ternary Complex with High Agonist Affinity
Gurevich, V. V., Pals-Rylaarsdam, R., Benovic, J. L., Hosey, M. M., & Onorato, J. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28849 · Cited by 184
Krasel, C., Bünemann, M., Lorenz, K., & Lohse, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413078200 · Cited by 178
Ma, P., & Zemmel, R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd884 · Cited by 174
Povsic, T. J., Kohout, T. A., & Lefkowitz, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309968200 · Cited by 174
Self-citationSchwartz, T. W., & Holst, B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.008 · Cited by 173
Charest, P. G., Terrillon, S., & Bouvier, M. (2005) · EMBO reports · doi:10.1038/sj.embor.7400373 · Cited by 172
Lagane, B., Chow, K. Y. C., Balabanian, K., Levoye, A., Harriague, J., Planchenault, T., Baleux, F., Gunera-Saad, N., Arenzana-Seisdedos, F., & Bachelerie, F. (2008) · Blood · doi:10.1182/blood-2007-07-102103 · Cited by 171
Zhai, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25330 · Cited by 171
Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G., & Barak, L. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.106 · Cited by 171
Self-citationRosanò, L., Cianfrocca, R., Masi, S., Spinella, F., Di Castro, V., Biroccio, A., Salvati, E., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807158106 · Cited by 164
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
Ahn, S., Kim, J., Hara, M. R., Ren, X.-R., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808463200 · Cited by 159
Self-citationCrosstalk between G-protein-coupled receptors and Epidermal growth factor receptor in cancer
Bhola, N. (2008) · Frontiers in Bioscience · doi:10.2741/2805 · Cited by 158
Molecular basis of inverse agonism in a G protein–coupled receptor
Vilardaga, J., Steinmeyer, R., Harms, G. S., & Lohse, M. J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio705 · Cited by 147
β-Arrestin is a necessary component of Wnt/β-catenin signaling in vitro and in vivo
Bryja, V., Gradl, D., Schambony, A., Arenas, E., & Schulte, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611356104 · Cited by 139
Rochais, F., Vilardaga, J., Nikolaev, V. O., Bünemann, M., Lohse, M. J., & Engelhardt, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30012 · Cited by 138
Nicotinic acid: an old drug with a promising future
Bodor, E. T., & Offermanns, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707528 · Cited by 138
Imamura, T., Huang, J., Dalle, S., Ugi, S., Usui, I., Luttrell, L. M., Miller, W. E., Lefkowitz, R. J., & Olefsky, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105364200 · Cited by 134
Self-citationGurwitz, D., Haring, R., Heldman, E., Fraser, C. M., Manor, D., & Fisher, A. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90220-8 · Cited by 129
Bertrand, L., Parent, S., Caron, M., Legault, M., Joly, E. C., Angers, S., Bouvier, M., Brown, M., Houle, B., & Ménard, L. (2002) · Journal of Receptors and Signal Transduction · doi:10.1081/rrs-120014619 · Cited by 129
Arrestins Block G Protein-coupled Receptor-mediated Apoptosis
Revankar, C. M., Vines, C. M., Cimino, D. F., & Prossnitz, E. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402121200 · Cited by 124
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
Hunton, D. L., Barnes, W. G., Kim, J., Ren, X.-R., Violin, J. D., Reiter, É., Milligan, G., Patel, D. D., & Lefkowitz, R. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006270 · Cited by 123
Self-citationGelber, E. I., Kroeze, W. K., Roth, B. L., Gray, J. A., Sinar, C. A., Hyde, E. G., Gurevich, V. V., Benovic, J., & Roth, B. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722206.x · Cited by 116
Moya, P. R., Berg, K. A., Gutierrez-Hernandez, M., Sáez‐Briones, P., Reyes-Parada, M. I., Cassels, B. K., & Clarke, W. P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117507 · Cited by 115
Gáborik, Z., Jagadeesh, G., Zhang, M., Spät, A., Catt, K. J., & Hunyady, L. (2003) · Endocrinology · doi:10.1210/en.2002-0135 · Cited by 112
Kim, J., Ahn, S., Rajagopal, K., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808176200 · Cited by 111
Self-citationβ-Arrestin-mediated Signaling Regulates Protein Synthesis
DeWire, S. M., Kim, J., Whalen, E. J., Ahn, S., Chen, M., & Lefkowitz, R. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710515200 · Cited by 105
Self-citationSemple, G., Skinner, P. J., Gharbaoui, T., Shin, Y., Jung, J., Cherrier, M. C., Webb, P. J., Tamura, S. Y., Boatman, P. D., Sage, C. R., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800258p · Cited by 104
Eglen, R. M., Bossé, R., & Reisine, T. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.062 · Cited by 90
Goel, R., Phillips‐Mason, P. J., Raben, D. M., & Baldassare, J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108995200 · Cited by 86
β Galactosidase Complementation: A Cell-Based Luminescent Assay Platform for Drug Discovery
Olson, K. R., & Eglen, R. M. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.052 · Cited by 80
β‐Arrestin2 functions as a phosphorylation‐regulated suppressor of UV‐induced NF‐κB activation
Luan, B., Zhang, Z., Wu, Y., Kang, J., & Pei, G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600882 · Cited by 69
Novel function of β-arrestin2 in the nucleus of mature spermatozoa
Neuhaus, E. M., Mashukova, A., Barbour, J., Wolters, D. A., & Hatt, H. H. (2006) · Journal of Cell Science · doi:10.1242/jcs.03046 · Cited by 68
Cell‐based assays in GPCR drug discovery
Siehler, S. (2008) · Biotechnology Journal · doi:10.1002/biot.200800001 · Cited by 66
Imaging CXCR4 Signaling with Firefly Luciferase Complementation
Luker, K. E., Gupta, M., & Luker, G. D. (2008) · Analytical Chemistry · doi:10.1021/ac8005457 · Cited by 57
Mo, W., Zhang, L., Yang, G., Zhai, J., Hu, Z., Chen, Y., Chen, X., Hui, L., Huang, R., & Hu, G. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.017 · Cited by 52
G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors
Verkaar, F., van Rosmalen, J. W. G., Blomenröhr, M., van Koppen, C. J., Blankesteijn, W. M., Smits, J. F. M., & Zaman, G. J. R. (2008) · Biotechnology annual review · doi:10.1016/s1387-2656(08)00010-0 · Cited by 36
β-arrestin 2 modulates the activity of nuclear receptor RAR β2 through activation of ERK2 kinase
Piu, F., Gauthier, N. K., & Wang, F. (2005) · Oncogene · doi:10.1038/sj.onc.1209024 · Cited by 19
High‐Content Screening of Known G Protein‐Coupled Receptors by Arrestin Translocation
Hudson, C. C., Oakley, R. H., Sjaastad, M. D., et al. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14005-7 · Cited by 18
Functional Selectivity at Serotonin Receptors
Berg, K. A., & Clarke, W. P. (2009) · The Receptors · doi:10.1007/978-1-60327-335-0_9 · Cited by 6
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., Kobayashi, M., Hirasawa, A., & Tsujimoto, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016088108 · Cited by 1,106
GPCR Dynamics: Structures in Motion
Latorraca, N. R., Venkatakrishnan, A. J., & Dror, R. O. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00177 · Cited by 835
Metadata
- Authors
- Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-05
- Volume
- 9
- Issue
- 5
- Pages
- 373-386
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2147196684
- Cited by
- 825
- References
- 114
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.